Cargando…

Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC)

OBJECTIVE: This study is aimed at investigating the clinical intervention effect of afatinib targeted therapy in patients with non-small-cell lung cancer. METHODS: The research object was a retrospective analysis of 86 patients with non-small-cell lung cancer who were admitted to our hospital from 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Wei, Ma, Jun, Jiang, Xuan, Gao, Guangyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492325/ https://www.ncbi.nlm.nih.gov/pubmed/36157204 http://dx.doi.org/10.1155/2022/2869531

Ejemplares similares

Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma
por: Cheng, Yizhuang, et al.
Publicado: (2019)

Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis
por: Choi, YunJeong, et al.
Publicado: (2020)

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
por: Wojcik, Ewa, et al.
Publicado: (2017)

Central ventilatory and cardiovascular actions of trout gastrin-releasing peptide (GRP) in the unanesthetized trout
por: Le Mével, Jean-Claude, et al.
Publicado: (2013)

Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
por: Gomena, Jacopo, et al.
Publicado: (2023)

Serum Cystatin, Chemokine, and Gastrin-Releasing Peptide Precursors and Their Clinical Value in Patients with Chronic Renal Failure
por: Liu, Xiaoli, et al.
Publicado: (2022)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer
por: Lv, Shui ping, et al.
Publicado: (2017)

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist (68)Ga-NODAGA-MJ9
por: Gnesin, Silvano, et al.
Publicado: (2018)

The influence of different blood samples treatment methods on pro-gastrin-releasing peptide
por: Jiang, Huiqin, et al.
Publicado: (2019)

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review
por: Jiang, Yingying, et al.
Publicado: (2023)

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings
por: Harvey, R Donald, et al.
Publicado: (2020)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
por: Wei, Yang, et al.
Publicado: (2021)

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
por: Niu, Mengmeng, et al.
Publicado: (2021)

Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors
por: Accardo, Antonella, et al.
Publicado: (2016)

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
por: Tan, Wan-Ling, et al.
Publicado: (2018)

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR ‐mutated NSCLC treated with afatinib
por: Wu, Chen‐Te, et al.
Publicado: (2023)

Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib
por: Yamamoto, Nobuyuki, et al.
Publicado: (2019)

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis
por: Pendharkar, Sayali A., et al.
Publicado: (2017)

Analgesic effect of gastrin-releasing peptide in the dorsal horn
por: Saeki, Ayano, et al.
Publicado: (2022)

Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report
por: Nakagawa, Natsuki, et al.
Publicado: (2023)

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist (68)Ga-RM2 and (18)F-FDG in breast cancer samples
por: Morgat, Clément, et al.
Publicado: (2019)

Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex
por: Cao, XiaoYan, et al.
Publicado: (2010)

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
por: Tan, Wan-Ling, et al.
Publicado: (2018)

Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
por: Lin, Ling, et al.
Publicado: (2020)

Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report
por: Nozaki, Koichiro, et al.
Publicado: (2022)

Exceptional response to afatinib in a patient with persistent G719A EGFR-mutant NSCLC
por: Kulkarni, Amit A, et al.
Publicado: (2022)

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer
por: Nisman, Benjamin, et al.
Publicado: (2016)

Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study
por: Ueland, Thor, et al.
Publicado: (2018)

Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer
por: Wang, Jin-Ping, et al.
Publicado: (2019)

Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
por: Miao, Qiang, et al.
Publicado: (2023)

Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis
por: Green, Paul G
Publicado: (2005)

How Gastrin-Releasing Peptide Opens the Spinal Gate for Itch
por: Pagani, Martina, et al.
Publicado: (2019)

Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
por: Rurarz, Beata Paulina, et al.
Publicado: (2023)

Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia, and the spinal cord
por: Goswami, Samridhi C, et al.
Publicado: (2014)

Oxygen, Gastrin-Releasing Peptide, and Pediatric Lung Disease: Life in the Balance
por: Sunday, Mary E.
Publicado: (2014)

Inhibition of Gastrin-Releasing Peptide Attenuates Phosphate-Induced Vascular Calcification
por: Park, Hyun-Joo, et al.
Publicado: (2020)

Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
por: Krawczyk, Paweł, et al.
Publicado: (2015)

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
por: Zöchbauer-Müller, Sabine, et al.
Publicado: (2021)

Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer
por: Lee, Haeyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gu1b236dpr9pcgfp445l71pu3c